Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Return on Assets (2016 - 2025)

Historic Return on Assets for Silo Pharma (SILO) over the last 13 years, with Q3 2025 value amounting to 0.78%.

  • Silo Pharma's Return on Assets fell 3300.0% to 0.78% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.78%, marking a year-over-year decrease of 3300.0%. This contributed to the annual value of 0.58% for FY2024, which is 5700.0% down from last year.
  • According to the latest figures from Q3 2025, Silo Pharma's Return on Assets is 0.78%, which was down 3300.0% from 0.78% recorded in Q2 2025.
  • Over the past 5 years, Silo Pharma's Return on Assets peaked at 0.0% during Q4 2022, and registered a low of 0.78% during Q2 2025.
  • Moreover, its 5-year median value for Return on Assets was 0.36% (2023), whereas its average is 0.32%.
  • In the last 5 years, Silo Pharma's Return on Assets surged by 19000bps in 2021 and then tumbled by -5400bps in 2023.
  • Quarter analysis of 5 years shows Silo Pharma's Return on Assets stood at 0.02% in 2021, then skyrocketed by 100bps to 0.0% in 2022, then crashed by -575629bps to 0.54% in 2023, then dropped by -1bps to 0.55% in 2024, then plummeted by -42bps to 0.78% in 2025.
  • Its Return on Assets was 0.78% in Q3 2025, compared to 0.78% in Q2 2025 and 0.69% in Q1 2025.